Sam Ricchezza

is the Vice President, Business Development for WellSpring Pharma Services. He has over 18 years of business development and marketing experience in the pharmaceutical contract development and manufacturing industry. He has held a number of progressively responsible business development positions over the course of his career with Patheon, DPT Laboratories, AAIPharma and WellSpring. Sam is also a member of “Contract Pharma’s” Editorial Advisory Board.
Find me on:

Recent Posts

WellSpring Completes $3 Million Capital Investment and Forms New Partnership

Posted by Sam Ricchezza

Oakville, Ontario, April 7, 2016 — WellSpring Pharma Services, leading specialists in formulation, development and manufacturing for a wide range of solid, semi-solid and non-sterile liquid products, has announced a $3 million capital investment in new equipment as well as a new strategic partnership with IDT Australia Ltd. to manufacture drugs targeting the U.S. market.

more

WellSpring Pharma Services Wins CMO Leadership Awards

Posted by Sam Ricchezza

WellSpring Pharma Services has been awarded the 2015 CMO Leadership Awards for excellence in Quality and excellence in Regulatory, as determined by independant research. This is the second year in a row that WellSpring has won a CMO Leadership Award.

Life Science Leader magazine hosts the CMO Leadership Awards Reception and Ceremony at the “W” New York Hotel, across from the Waldorf-Astoria on March 18, 2014.

more

Topics: Awards and Accreditations

WellSpring Pharma Services Wins Quality Award

Posted by Sam Ricchezza

WellSpring Pharma Services has been awarded the 2013 CMO Leadership Quality Award, as determined by research canvassing over 11,000 buyers of outsourced pharmaceutical services to determine perception and awareness of Contract Manufacturing Organizations (CMOs) for five different attributes:

  • Innovation
  • Productivity
  • Quality
  • Regulatory
  • Reliability
more

Topics: Awards and Accreditations